Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,302 warrant series at 1,050 companies. 778 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 4 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Junior Note Warrants (November 2023 original issuance) | $0.2329 | $2.4M | 10-Q/A, Sep 22, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Public Warrants (assumed from Tailwind SPAC) | $0.2329 | $2.4M | 10-Q/A, Sep 22, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Q2 2026 Indigo Pre-Funded Warrants | $0.2329 | $2.4M | 10-Q/A, Sep 22, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| IPO Representative (Underwriter) Warrants | $0.3196 | $2.4M | 20-F, Apr 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2026 Placement Agent Warrants (FT Global) | $0.3196 | $2.4M | 424B3, Aug 20, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2026 Private (Investor) Warrants | $0.3196 | $2.4M | 424B5, Jun 18, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Conversion Common Stock Warrants (Secured Note debt conversion, May 2025) | $0.7767 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| February 2026 Common Stock Warrants | $0.7767 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| May 2026 Common Stock Warrants | $0.7767 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| November 2025 Inducement Common Stock Warrants (New Warrants) | $0.7767 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| 2024 Common Warrants (Armistice, amended) | $0.1201 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2024 Common Warrants (not subject to amendment) | $0.1201 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2026 PIPE Common Warrants | $0.1201 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2026 PIPE Pre-Funded Warrants | $0.1201 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Placement Agent Warrants (2026 Offering) | $0.1201 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2026 Common Warrants (registered offering closed August 4, 2026) | $0.8872 | $2.4M | 6-K, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| July 2026 Common Warrants (registered offering closed July 13, 2026) | $0.8872 | $2.4M | 6-K, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| May 2026 Common Warrants (registered offering closed May 18, 2026) | $0.8872 | $2.4M | 6-K, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| New Warrants (November 2026 warrant inducement, private placement) | $0.8872 | $2.4M | 6-K, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| December 2023 warrants (broker/placement agent) | $0.6610 | $2.4M | 20-F, Mar 26, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Warrants issued to underwriters (April 15, 2024) | $0.6610 | $2.4M | 20-F, Mar 26, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Warrants issued to underwriters (December 18, 2024) | $0.6610 | $2.4M | 6-K EX-99.1, Sep 3, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Warrants issued to underwriters (September 11, 2024) | $0.6610 | $2.4M | 424B3, Dec 12, 2024Dilution tabAs of Oct 5, 2026 | ||||||||
| August 2023 Common Stock warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2023 Placement Agent warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class A warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class B warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class C warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class E warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2024 Placement Agent warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2024 warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2026 Placement Agent warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2026 Pre-funded warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series F Placement Agent warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series F warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series G warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series H warrants | $2.15 | $2.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| February 2025 Agent Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| February 2025 Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| January 2024 Representative Warrants | $0.5341 | $2.4M | 10-K, Mar 30, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| January 2024 Warrants | $0.5341 | $2.4M | 10-K, Mar 30, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| January 2025 Agent Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| January 2025 Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| July 2025 Placement Agent Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| July 2025 Series A-1 Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| July 2025 Series A-2 Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| July 2026 Agent Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| July 2026 Series A Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| July 2026 Series B Warrants | $0.5341 | $2.4M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Pre-2024 legacy warrants (opening balance at December 31, 2023, not itemised) | $0.5341 | $2.4M | 10-K, Mar 30, 2026Dilution tabAs of Nov 16, 2026 |
BURUNuburu, Inc.$0.2329Last price
Junior Note Warrants (November 2023 original issuance)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BURUNuburu, Inc.$0.2329Last price
Public Warrants (assumed from Tailwind SPAC)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BURUNuburu, Inc.$0.2329Last price
Q2 2026 Indigo Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
MTENMingteng International Corporation Inc. Class A Ordinary Shares$0.3196Last price
IPO Representative (Underwriter) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
MTENMingteng International Corporation Inc. Class A Ordinary Shares$0.3196Last price
June 2026 Placement Agent Warrants (FT Global)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
MTENMingteng International Corporation Inc. Class A Ordinary Shares$0.3196Last price
June 2026 Private (Investor) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
HCWBHCW Biologics Inc.$0.7767Last price
Conversion Common Stock Warrants (Secured Note debt conversion, May 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
HCWBHCW Biologics Inc.$0.7767Last price
February 2026 Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
HCWBHCW Biologics Inc.$0.7767Last price
May 2026 Common Stock Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
HCWBHCW Biologics Inc.$0.7767Last price
November 2025 Inducement Common Stock Warrants (New Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
VIVSVivoSim Labs, Inc.$0.1201Last price
2024 Common Warrants (Armistice, amended)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
VIVSVivoSim Labs, Inc.$0.1201Last price
2024 Common Warrants (not subject to amendment)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
VIVSVivoSim Labs, Inc.$0.1201Last price
2026 PIPE Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
VIVSVivoSim Labs, Inc.$0.1201Last price
2026 PIPE Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
VIVSVivoSim Labs, Inc.$0.1201Last price
Placement Agent Warrants (2026 Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
ELPWElong Power Holding Limited Class A Ordinary Shares$0.8872Last price
August 2026 Common Warrants (registered offering closed August 4, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
ELPWElong Power Holding Limited Class A Ordinary Shares$0.8872Last price
July 2026 Common Warrants (registered offering closed July 13, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
ELPWElong Power Holding Limited Class A Ordinary Shares$0.8872Last price
May 2026 Common Warrants (registered offering closed May 18, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
ELPWElong Power Holding Limited Class A Ordinary Shares$0.8872Last price
New Warrants (November 2026 warrant inducement, private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
PRFXPRF Technologies Ltd. Ordinary Shares$0.6610Last price
December 2023 warrants (broker/placement agent)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
PRFXPRF Technologies Ltd. Ordinary Shares$0.6610Last price
Warrants issued to underwriters (April 15, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
PRFXPRF Technologies Ltd. Ordinary Shares$0.6610Last price
Warrants issued to underwriters (December 18, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
PRFXPRF Technologies Ltd. Ordinary Shares$0.6610Last price
Warrants issued to underwriters (September 11, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
August 2023 Common Stock warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
August 2023 Placement Agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
Class A warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
Class B warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
Class C warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
Class E warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
January 2024 Placement Agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
January 2024 warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
June 2026 Placement Agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
June 2026 Pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
Series F Placement Agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
Series F warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
Series G warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
BJDXBluejay Diagnostics, Inc.$2.15Last price
Series H warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
February 2025 Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
February 2025 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
January 2024 Representative Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
January 2024 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
January 2025 Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
January 2025 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
July 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
July 2025 Series A-1 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
July 2025 Series A-2 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
July 2026 Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
July 2026 Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
July 2026 Series B Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
SXTP60 Degrees Pharmaceuticals, Inc.$0.5341Last price
Pre-2024 legacy warrants (opening balance at December 31, 2023, not itemised)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.4M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,062 dilution snapshots. 4,848 of 5,302 series state an exercise price and 3,366 an expiry date. 121 record when exercise begins; that count grows as companies are re-extracted. 631 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.